| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Doraiswamy Vinayak is a Chief Scientific Officer at ATRC. Recent filings cover 0 purchases and 7 sales. Those positions are worth an estimated $3.4M at current prices.
Our model assigns Doraiswamy Vinayak a middling insider score of 64/100, based on 7 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +15.8%.
Doraiswamy Vinayak's largest disclosed position is in ATRC as Chief Scientific Officer, worth about $3.4M. The recent filings there lean toward selling, a net 33,655 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 6,000 | $38.88 | $233,280.00 | -6.5% | +48.4% | - | |
| May 15, 2026 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 5,000 | $28.13 | $140,650.00 | -5.2% | +54.7% | - | |
| Mar 12, 2026 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 5,000 | $29.83 | $149,150.00 | -4.9% | -6.9% | - | |
| Aug 5, 2025 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91,450.00 | -3.4% | -9.4% | +4.8% | |
| May 28, 2025 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83,600.00 | -3.3% | +12.9% | -16.2% | |
| Sep 15, 2022 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 4,983 | $45.99 | $229,168.17 | -20.4% | -4.3% | -2.7% | |
| Jul 12, 2021 | ATRC Atricure, Inc. | Chief Scientific Officer | Sell | 7,672 | $83.12 | $637,696.64 | -31.3% | -16.2% | -49.1% |